(Q44657166)

English

Effects of the Angiotensin II Subtype 1 Receptor Antagonist Losartan on Functional Recovery of Isolated Rat Hearts Undergoing Global Myocardial Ischemia‐Reperfusion

scientific article published on November 1, 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Effects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Effects of the Angiotensin II Subtype 1 Receptor Antagonist Losartan on Functional Recovery of Isolated Rat Hearts Undergoing Global Myocardial Ischemia‐Reperfusion (English)

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

1 reference

based on heuristic

inferred from title

author name string

Jeremy D. Flynn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14620386

2 April 2024

Wendell S. Akers

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14620386

2 April 2024

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1592%2Fphco.23.14.1401.31947

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

https://onlinelibrary.wiley.com/doi/full/10.1592/phco.23.14.1401.31947

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1401-1410

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Cellular and molecular therapeutic targets for treatment of contractile dysfunction after cardioplegic arrest

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Cardiovascular Morbidity and CABG Surgery?A Perspective: Epidemiology, Costs, and Potential Therapeutic Solutions

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Fundamentals of reperfusion injury for the clinical cardiologist.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Ischemic preconditioning: from basic mechanisms to clinical applications

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Preconditioning and postresuscitation injury

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

AT1 receptor blockade in experimental myocardial ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Pharmacological possibilities for protection against myocardial reperfusion injury

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

The isolated blood and perfusion fluid perfused heart

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Ischemic cardiomyopathy and the cellular renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Signal transduction from the angiotensin II AT2 receptor

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

Regulation of stress-activated protein kinase signaling pathways by protein phosphatases

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.14.1401.31947

21 January 2018

The preconditioning phenomenon: A tool for the scientist or a clinical reality?

6

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Ischemic preconditioning in humans: models, mediators, and clinical relevance

8

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size

11

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Angiotensin converting enzyme inhibitors and ischaemic heart disease

12

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Effects of four angiotensin I converting enzyme inhibitors on regional myocardial blood flow and ischemic injury during coronary artery occlusion in dogs

14

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

The angiotensin II AT1-receptor antagonist candesartan improves functional recovery and reduces the no-reflow area in reperfused ischemic rat hearts

16

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts

17

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Renin-angiotensin system and sympathetic nervous system in cardiac pressure-overload hypertrophy

18

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Effects of an angiotensin II antagonist on ischemic and nonischemic isolated rat hearts

20

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts

22

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts

23

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts

24

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Characterization of cardioprotection mediated by AT2 receptor antagonism after ischemia-reperfusion in isolated working rat hearts

25

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion

27

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence

29

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats

32

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats

34

1 reference

10.1592/PHCO.23.14.1401.31947

https://api.crossref.org/works/10.1592/PHCO.23.14.1401.31947

2 April 2024

Identifiers

10.1592/PHCO.23.14.1401.31947

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44657166&oldid=2117167443"